Most complaints about GLP-1 drugs made through the MHRA’s Yellow Card scheme were concerning gastrointestinal reactions

Il boom dei GLP‑1 tra risultati clinici straordinari e la sfida della farmacosorveglianza

Most complaints about GLP-1 drugs made through the MHRA’s Yellow Card scheme were concerning gastrointestinal reactions